Assyro AI

Orange Book product · Generic (ANDA)

ETRAVIRINE

ETRAVIRINE

Generic (ANDA)ANDA 215402TE ABRX CARNEGIE

At a glance

Apr 13, 2022

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 13, 2022

    4 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ETRAVIRINE

Strength

100MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 215402

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ETRAVIRINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.